Health and Me

Tanya Dutt

Man Walks Into ER Feeling Unwell, Hours Later Starts Hallucinating—Now He’s Battling A Rare Disorder That Mimics Mental Illness

When 48-year-old Ryan Alto from California walked into the emergency room with what seemed like mild flu symptoms, no one—not even he—could have predicted how rapidly things would spiral. Within hours, he was hallucinating. Soon after, he lost consciousness. By the end of the day, Ryan had slipped into a coma. What doctors discovered next would upend everything his family knew about illness, mental health, and recovery.

He wasn’t battling a virus. He wasn’t having a psychiatric breakdown. Ryan had Anti-NMDA Receptor Encephalitis—a rare, <span>autoimmune brain disorder</span> so misunderstood it’s often mistaken for mental illness.

<h2>What is <span rel="noindex">Brain on Fire Disease</span>?</h2>

Anti-NMDA Receptor Encephalitis, sometimes referred to as “Brain on Fire” disease, is caused when the body's immune system mistakenly attacks NMDA receptors in the brain. These receptors play a key role in memory, cognition, and behavior. When they malfunction, it can look eerily similar to a psychiatric or neurological breakdown.

<h2>Symptoms of Brain on Fire Disease</h2>

Initially, patients often present with flu-like symptoms: mild fever, fatigue, headaches. But in a matter of days, things can shift dramatically—paranoia, hallucinations, speech problems, seizures, and even catatonia may emerge.

In Ryan’s case, these escalated quickly. He started speaking incoherently. He experienced delusions, then seizures, and within days, fell into a coma that lasted eight weeks. When he woke up, the world was unrecognizable. He couldn't stand, speak, or even identify familiar faces.

Anti-NMDA receptor encephalitis affects an estimated 1.5 people per million annually, but that number may be underreported due to frequent misdiagnosis. Its symptoms mimic schizophrenia, bipolar disorder, or severe anxiety, often delaying correct treatment.

Women, especially between ages 12 to 45, are disproportionately affected. In these cases, the condition is frequently associated with tumors, particularly ovarian teratomas, which trigger the immune response. For others, it can follow a herpes simplex infection—another key but underrecognized link.

A study published in Neurology found that nearly 27% of patients recovering from herpes simplex encephalitis went on to develop autoimmune encephalitis, with Anti-NMDAR accounting for the majority of those cases.

<h2>Can 'Brain on Fire Disease' Be Treated?</h2>

The key to managing this condition lies in quick recognition and aggressive early treatment. But diagnosis isn’t straightforward. Blood and cerebrospinal fluid tests are needed to detect the anti-NMDA antibodies, which can take time—time many patients don’t have.

That’s why most experts recommend beginning immunotherapy based on clinical suspicion, even before test results are back.

Treatment typically begins with high-dose steroids, intravenous immunoglobulin (IVIG), or plasmapheresis to suppress the immune attack. If a tumor is detected, surgical removal becomes urgent. In more stubborn or recurring cases, drugs like rituximab or cyclophosphamide are introduced for long-term immune modulation.

In Ryan’s case, immunotherapy began after his coma was induced to manage seizures and brain swelling. Since regaining consciousness, his recovery has been slow but steady. He remains disoriented and confused, sometimes mistaking objects or people for things they’re not—a stuffed toy, to him, is a living creature. He’s learning to move again, a process his family says may take up to a year or more.

One of the most challenging aspects of anti-NMDA receptor encephalitis is managing its psychiatric manifestations. Patients can swing between aggression, hallucinations, mutism, and catatonia—often within hours. That’s why psychiatric support is as crucial as neurological intervention.

Medications like benzodiazepines, valproic acid, and certain antipsychotics like quetiapine are commonly used to manage behavioral symptoms. But the challenge lies in balance: too much sedation can worsen neurological symptoms like abnormal movements or cognitive delays.

Doctors typically tailor medication regimens carefully, opting for sleep aids like trazodone or clonidine when needed and tapering off psychiatric drugs as neurological recovery improves.

<h2>How Treatment Helps Manage Seizures?</h2>

Seizures are common in anti-NMDA receptor encephalitis and often the first visible signs of a deeper problem. Most patients experience focal or generalized seizures, and while immunotherapy usually helps reduce them, anti-seizure medications are added to prevent complications.

Interestingly, sodium channel blockers tend to perform better than some commonly used medications like levetiracetam, which can worsen psychiatric symptoms. Most patients can eventually taper off anti-epileptics after two to three years of stability.

Unfortunately, yes. Relapses are a real possibility, even years after initial recovery. This underscores the need for long-term monitoring. Experts advise follow-ups with a neuroimmunologist, especially if the original trigger—like a tumor—was never identified.

If relapse occurs, doctors recommend treating it as aggressively as the first time: re-evaluation for tumors, renewed immunotherapy, and psychiatric support.

If you or someone you know starts showing sudden, unexplained changes in behavior—especially after a recent infection or illness—don’t dismiss it. Ask about autoimmune encephalitis. Because sometimes, what looks like a breakdown… is actually the brain crying out for help.

Health Conditions A-Z

health

brain on fire disease

anti nmda receptor encephalitis

autoimmune brain disorder

hallucinations and seizures

rare neurological illness

mental illness mimic

encephalitis treatment

3 Medical Emergencies Schools Should Be Prepared For - Biggest Concerns For Paramedic Responses

A Mix Of 96 Chemicals And Hidden Toxins Found In 90% of U.S. Toddlers, Reveals NHS Study

Health & Wellness

Low-Calorie Foods That Keep You Full For Long

Yoga Poses That Help You Get Rid Of Back Pain

Natural Ways To Increase Protein In Your Diet

Managing Excessive Daytime Sleepiness – Tips To Try

How Much Protein Is Too Much?

High Fiber Indian Foods You Should Try

10 Easy Ways To Boost Daily Fiber Intake

Adding Walnut Oil To Your Diet? Benefits You Should Know

Drinks That Soothe Headaches And Migraines

Waist Exercises For More Toned Belly

This Is How Stress Affects Your Heart

Does Digital ‘Brain Rot’ Really Affect Your Health?

Dishes With Fermented Foods To Eat For Your Gut Health

Yoga Poses That Stimulate Good Bowel Health

Weekend Warrior Exercises For Full Body Movement

Weekend Meal Prep Ideas That Will Last You A Weekend

Easy Homemade Healthy Dishes For Long Afternoons

Silent Walking: Mental Health Booster That Keeps You Fit

Dumbbell Exercises You Can Do At Home

These Foods Are Keeping You Awake At Night

Ways to Manage Sugar Cravings

Your Body Doesn’t Want You To Lose Weight – Here's It Resists

High-Protein No Cook Dishes You Should Try

Yoga Poses That Aid In Digestion

Low Calorie Dinner Options For Weight Loss

Cardiac Arrest Vs. Heart Attack: Difference Explained Under 60 Seconds

High Protein Low-Carb Snacks To Have On The Go

Knee Exercises Desk Workers Should Do For Joint Health

Why Do I Feel Sleepy During The Day?

High Protein Early Morning Meals To Keep You Full Till Lunch

International Yoga Day 2025: Benefits of Doing Tadasana Every Morning

High-Carb Foods That Are Really Healthy

Dementia Vs Alzheimer’s: Difference Explained Under 60 Seconds

Healthy Staple Foods To Make Eating Healthy Easier

Are You Dealing With Abandonment Issues? Signs And Risk Factors

Mid-Work Healthy Snacks You Can Eat Throughout The Day

Common Mistakes You May Be Making In The Gym

Strengthen Your Legs Muscles With These Exercises

Beat Anxiety With Books: How Reading Helps With Stress

Ghee For Health: Ayurvedic Health Benefits Of Clarified Butter

When 48-year-old Ryan Alto from California walked into the emergency room with what seemed like mild flu symptoms, no one—not even he—could have predicted how rapidly things would spiral. Within hours, he was hallucinating. Soon after, he lost consciousness. By the end of the day, Ryan had slipped into a coma. What doctors discovered next would upend everything his family knew about illness, mental health, and recovery.He wasn’t battling a virus. He wasn’t having a psychiatric breakdown. Ryan had Anti-NMDA Receptor Encephalitis—a rare, autoimmune brain disorder so misunderstood it’s often mistaken for mental illness.What is Brain on Fire Disease?Anti-NMDA Receptor Encephalitis, sometimes referred to as “Brain on Fire” disease, is caused when the body's immune system mistakenly attacks NMDA receptors in the brain. These receptors play a key role in memory, cognition, and behavior. When they malfunction, it can look eerily similar to a psychiatric or neurological breakdown.Symptoms of Brain on Fire DiseaseInitially, patients often present with flu-like symptoms: mild fever, fatigue, headaches. But in a matter of days, things can shift dramatically—paranoia, hallucinations, speech problems, seizures, and even catatonia may emerge.In Ryan’s case, these escalated quickly. He started speaking incoherently. He experienced delusions, then seizures, and within days, fell into a coma that lasted eight weeks. When he woke up, the world was unrecognizable. He couldn't stand, speak, or even identify familiar faces.Anti-NMDA receptor encephalitis affects an estimated 1.5 people per million annually, but that number may be underreported due to frequent misdiagnosis. Its symptoms mimic schizophrenia, bipolar disorder, or severe anxiety, often delaying correct treatment.Women, especially between ages 12 to 45, are disproportionately affected. In these cases, the condition is frequently associated with tumors, particularly ovarian teratomas, which trigger the immune response. For others, it can follow a herpes simplex infection—another key but underrecognized link.A study published in Neurology found that nearly 27% of patients recovering from herpes simplex encephalitis went on to develop autoimmune encephalitis, with Anti-NMDAR accounting for the majority of those cases.Can 'Brain on Fire Disease' Be Treated?The key to managing this condition lies in quick recognition and aggressive early treatment. But diagnosis isn’t straightforward. Blood and cerebrospinal fluid tests are needed to detect the anti-NMDA antibodies, which can take time—time many patients don’t have.That’s why most experts recommend beginning immunotherapy based on clinical suspicion, even before test results are back.Treatment typically begins with high-dose steroids, intravenous immunoglobulin (IVIG), or plasmapheresis to suppress the immune attack. If a tumor is detected, surgical removal becomes urgent. In more stubborn or recurring cases, drugs like rituximab or cyclophosphamide are introduced for long-term immune modulation.In Ryan’s case, immunotherapy began after his coma was induced to manage seizures and brain swelling. Since regaining consciousness, his recovery has been slow but steady. He remains disoriented and confused, sometimes mistaking objects or people for things they’re not—a stuffed toy, to him, is a living creature. He’s learning to move again, a process his family says may take up to a year or more.One of the most challenging aspects of anti-NMDA receptor encephalitis is managing its psychiatric manifestations. Patients can swing between aggression, hallucinations, mutism, and catatonia—often within hours. That’s why psychiatric support is as crucial as neurological intervention.Medications like benzodiazepines, valproic acid, and certain antipsychotics like quetiapine are commonly used to manage behavioral symptoms. But the challenge lies in balance: too much sedation can worsen neurological symptoms like abnormal movements or cognitive delays.Doctors typically tailor medication regimens carefully, opting for sleep aids like trazodone or clonidine when needed and tapering off psychiatric drugs as neurological recovery improves.How Treatment Helps Manage Seizures?Seizures are common in anti-NMDA receptor encephalitis and often the first visible signs of a deeper problem. Most patients experience focal or generalized seizures, and while immunotherapy usually helps reduce them, anti-seizure medications are added to prevent complications.Interestingly, sodium channel blockers tend to perform better than some commonly used medications like levetiracetam, which can worsen psychiatric symptoms. Most patients can eventually taper off anti-epileptics after two to three years of stability.Can This Disease Come Back?Unfortunately, yes. Relapses are a real possibility, even years after initial recovery. This underscores the need for long-term monitoring. Experts advise follow-ups with a neuroimmunologist, especially if the original trigger—like a tumor—was never identified.If relapse occurs, doctors recommend treating it as aggressively as the first time: re-evaluation for tumors, renewed immunotherapy, and psychiatric support.If you or someone you know starts showing sudden, unexplained changes in behavior—especially after a recent infection or illness—don’t dismiss it. Ask about autoimmune encephalitis. Because sometimes, what looks like a breakdown… is actually the brain crying out for help.

man walks into er feeling unwell, hours later starts hallucinating—now he’s battling a rare disorder that mimics mental illness

Ishita Roy

Overweight Women With Heart Disease Face 31% Higher Breast Cancer Risk

76% Of Stomach Cancer Cases Are Linked to This Common Infection, But Not Many Know About It

76% of stomach cancer cases are linked to this common infection, but not many know about it

Fitness

Should Women Try This 'Gym Bro' Supplement To Help Boost Focus, Mood And Memory?

should women try this 'gym bro' supplement to help boost focus, mood and memory?

Turns Out, Exercise Might Be the Most Underrated Cancer Drug But Could It Do More Harm Than Good?

turns out, exercise might be the most underrated cancer drug but could it do more harm than good?

Health News

You Don’t Have To Smoke To Get Lung Cancer—Air Pollution May Be Just As Dangerous

you don’t have to smoke to get lung cancer—air pollution may be just as dangerous

Women carrying excess body fat face a significantly higher risk of developing <span>breast cancer</span> after menopause, new research has revealed. The risk climbs even higher for women who also suffer from heart disease—drawing attention to a worrying but often overlooked health intersection.

The study, led by Dr Heinz Freisling of the International Agency for Research on <span>Cancer</span> (IARC), part of the World Health Organization (WHO), analyzed health data from over 168,000 postmenopausal women. Their findings show a clear link between body mass index (BMI) and breast cancer risk—especially in those with pre-existing cardiovascular conditions.

<h4>The Connection Between Weight and Heart Health</h4>

The analysis found that for every 5kg/m² increase in BMI, the risk of breast cancer went up by 13% in women without heart disease. However, in women with heart disease, the same weight gain increased their risk by 31%.

To put this into perspective, researchers estimate that this dual burden of excess weight and heart disease could lead to 153 additional breast cancer cases per 100,000 women every year.

BMI is a standard measure used worldwide to evaluate a person’s weight category based on height and weight. While useful, it doesn’t fully capture individual health or fat distribution, making regular check-ups and a broader assessment all the more important.

“Excess weight can cause hormonal imbalances, particularly raising oestrogen levels, which are known to fuel breast cancer,” said Dr Freisling. “Our findings could help guide risk-based breast cancer screening programs and support tailored prevention strategies.”

This is not the first time obesity has been linked to breast cancer. Earlier this year, Danish researchers reported that obese breast cancer survivors were up to 80% more likely to die of the disease. The risk of recurrence was also found to increase by 70% in overweight women.

Researchers suspect that what’s known as metabolic syndrome—a cluster of conditions including high blood pressure, high blood sugar, and excess fat around the waist—could be to blame. It may create chronic inflammation in the body, weakening the immune system’s ability to fight off cancer cells.

<h4>Breast Cancer: The Most Common Cancer in the UK</h4>

Breast cancer remains the most frequently diagnosed cancer among women in the UK, with nearly 56,000 new cases annually. It is also one of the leading causes of cancer-related death, with approximately 11,500 women dying from the disease each year.

The majority of breast cancer cases occur in women over 50, particularly after menopause. But alarmingly, global data show that breast cancer is increasingly affecting women under 50, a trend that scientists are still trying to understand.

Projections suggest that by 2050, breast cancer deaths in the UK could rise by over 40%, with 3.2 million new cases and 1.1 million deaths expected globally if current trends continue.

Despite the sobering statistics, breast cancer is often treatable if caught early. Yet, more than a third of women in the UK still do not regularly check their breasts for signs of change.

<ul><li>A lump or swelling in the breast or armpit</li><li>Dimpling of the skin</li><li>Changes in nipple shape or discharge</li><li>Persistent rash or redness</li><li>Sudden changes in size or shape of the breast</li></ul>

Health experts and charities such as CoppaFeel continue to urge women to make breast self-checks a monthly routine, as reported by DailyMail. You can do it in the shower, lying down, or while getting dressed—there’s no right or wrong method, as long as you stay familiar with your own body.

The National Health Service, UK, also encourages women aged 50 to 70 to attend routine breast cancer screenings every three years. If you notice any persistent or unusual changes, speak to your GP immediately.

breast cancer

health and wellness

cancer

menopause and breast cancer

weight and breast cancer

womens health

reproductive health

Women carrying excess body fat face a significantly higher risk of developing breast cancer after menopause, new research has revealed. The risk climbs even higher for women who also suffer from heart disease—drawing attention to a worrying but often overlooked health intersection.The study, led by Dr Heinz Freisling of the International Agency for Research on Cancer (IARC), part of the World Health Organization (WHO), analyzed health data from over 168,000 postmenopausal women. Their findings show a clear link between body mass index (BMI) and breast cancer risk—especially in those with pre-existing cardiovascular conditions.The Connection Between Weight and Heart HealthThe analysis found that for every 5kg/m² increase in BMI, the risk of breast cancer went up by 13% in women without heart disease. However, in women with heart disease, the same weight gain increased their risk by 31%.To put this into perspective, researchers estimate that this dual burden of excess weight and heart disease could lead to 153 additional breast cancer cases per 100,000 women every year.BMI is a standard measure used worldwide to evaluate a person’s weight category based on height and weight. While useful, it doesn’t fully capture individual health or fat distribution, making regular check-ups and a broader assessment all the more important.“Excess weight can cause hormonal imbalances, particularly raising oestrogen levels, which are known to fuel breast cancer,” said Dr Freisling. “Our findings could help guide risk-based breast cancer screening programs and support tailored prevention strategies.”Obesity and Recurrence RiskThis is not the first time obesity has been linked to breast cancer. Earlier this year, Danish researchers reported that obese breast cancer survivors were up to 80% more likely to die of the disease. The risk of recurrence was also found to increase by 70% in overweight women.Researchers suspect that what’s known as metabolic syndrome—a cluster of conditions including high blood pressure, high blood sugar, and excess fat around the waist—could be to blame. It may create chronic inflammation in the body, weakening the immune system’s ability to fight off cancer cells.Breast Cancer: The Most Common Cancer in the UKBreast cancer remains the most frequently diagnosed cancer among women in the UK, with nearly 56,000 new cases annually. It is also one of the leading causes of cancer-related death, with approximately 11,500 women dying from the disease each year.The majority of breast cancer cases occur in women over 50, particularly after menopause. But alarmingly, global data show that breast cancer is increasingly affecting women under 50, a trend that scientists are still trying to understand.Projections suggest that by 2050, breast cancer deaths in the UK could rise by over 40%, with 3.2 million new cases and 1.1 million deaths expected globally if current trends continue.Prevention and Early DetectionDespite the sobering statistics, breast cancer is often treatable if caught early. Yet, more than a third of women in the UK still do not regularly check their breasts for signs of change.Symptoms to watch for include:A lump or swelling in the breast or armpitDimpling of the skinChanges in nipple shape or dischargePersistent rash or rednessSudden changes in size or shape of the breastHealth experts and charities such as CoppaFeel continue to urge women to make breast self-checks a monthly routine, as reported by DailyMail. You can do it in the shower, lying down, or while getting dressed—there’s no right or wrong method, as long as you stay familiar with your own body.The National Health Service, UK, also encourages women aged 50 to 70 to attend routine breast cancer screenings every three years. If you notice any persistent or unusual changes, speak to your GP immediately.

overweight women with heart disease face 31% higher breast cancer risk

Parenting

C-Section Births May Raise Odds Of Leukemia In Children, Study Finds

c-section births may raise odds of leukemia in children, study finds

A common stomach bug, Helicobacter pylori (H. pylori), could be responsible for millions of preventable <span>cancer</span> cases in the coming years, top researchers have warned.

Scientists from the International Agency for Research on Cancer (IARC), part of the World Health Organization (WHO), estimate that H. pylori infection causes 76% of all <span>stomach cancer</span> cases globally. Despite its serious implications, the infection is often silent, producing no noticeable symptoms beyond common digestive complaints.

<h4>No Obvious Signs Until It Is Too Late</h4>

The bacteria, which lives in the lining of the stomach, is usually acquired through contaminated food, water, or close contact with infected individuals. It causes tissue damage over time that can eventually lead to stomach cancer.

What makes it dangerous is that most people don't realize they're infected. “The vast majority—between 80 to 90 per cent—of infected individuals show no symptoms,” the researchers noted. In some cases, H. pylori may cause painful stomach ulcers, which is when it’s typically detected.

Symptoms of stomach cancer are often subtle in the beginning: 

<ul><li>persistent indigestion</li><li>bloating</li><li>heartburn</li><li>difficulty swallowing</li><li>feeling full quickly</li><li>unexplained weight loss</li><li>fatigue</li></ul>

These can easily be mistaken for common gastrointestinal issues, which delays diagnosis and treatment.

The IARC team is now calling for more widespread screening for H. pylori, using simple blood, breath or stool tests. Writing in the journal Nature Medicine, they warn that if current trends continue unchecked, nearly 12 million people born between 2008 and 2017 will go on to develop stomach cancer due to the bacteria.

“We found that about three-quarters of all stomach cancer cases globally could be prevented with proper screening and treatment,” said Dr Jin Young Park, lead author of the study and head of IARC’s gastric cancer prevention programme. “It is essential that health authorities make gastric cancer prevention a priority and accelerate efforts to control it.”

<h4>Asia Is Most Affected, But The Risk Is Global</h4>

While the highest number of predicted cases is expected in Asia, around 2 million are projected to develop in the Americas and 1.2 million in Europe.

In the UK, data from Cancer Research UK (CRUK) shows that H. pylori is responsible for roughly 41 per cent of the 6,500 stomach cancer cases diagnosed annually—about 2,700 cases a year.

Historically, about 40% of the British population has tested positive for H. pylori, although rates are now believed to be declining. However, the risk persists, especially among older generations or those born in areas where the bacteria is still widespread.

<h4>Prevention Lies In Lifestyle Changes</h4>

Despite the global warning, CRUK has urged Britons not to panic. Dr Rachel Orritt, the charity’s health information manager, stressed that lifestyle factors such as smoking, poor diet, alcohol consumption and obesity remain more significant contributors to cancer risk in the UK, as reported by DailyMail.

“Although this is an important issue worldwide, in the UK other preventable factors cause more cancer cases,” she said. “Ways to reduce your cancer risk include stopping smoking, keeping a healthy weight, cutting down on alcohol and eating a healthy, balanced diet.”

CRUK also highlighted that over half of all stomach cancers in the UK are preventable, and that incidence rates have fallen by more than 25% in the past decade—a trend that is expected to continue.

Doctors advise that persistent symptoms like indigestion, nausea, weight loss, or discomfort in the upper stomach lasting more than three weeks should prompt a visit to a GP. 

Around 18 people in the UK and 83 in the US are diagnosed with stomach cancer every day. The disease remains difficult to treat once advanced, with only 17 per cent of UK patients surviving beyond 10 years post-diagnosis.

With screening and treatment, H. pylori infection can be managed—and lives saved. The challenge lies in catching it before it silently progresses to something far more dangerous.

common infection that causes stomach cancer

stomach cancer

cancer stories

A common stomach bug, Helicobacter pylori (H. pylori), could be responsible for millions of preventable cancer cases in the coming years, top researchers have warned.Scientists from the International Agency for Research on Cancer (IARC), part of the World Health Organization (WHO), estimate that H. pylori infection causes 76% of all stomach cancer cases globally. Despite its serious implications, the infection is often silent, producing no noticeable symptoms beyond common digestive complaints.No Obvious Signs Until It Is Too LateThe bacteria, which lives in the lining of the stomach, is usually acquired through contaminated food, water, or close contact with infected individuals. It causes tissue damage over time that can eventually lead to stomach cancer.What makes it dangerous is that most people don't realize they're infected. “The vast majority—between 80 to 90 per cent—of infected individuals show no symptoms,” the researchers noted. In some cases, H. pylori may cause painful stomach ulcers, which is when it’s typically detected.Symptoms of stomach cancer are often subtle in the beginning: persistent indigestionbloatingheartburndifficulty swallowingfeeling full quicklyunexplained weight lossfatigueThese can easily be mistaken for common gastrointestinal issues, which delays diagnosis and treatment.Screening could save livesThe IARC team is now calling for more widespread screening for H. pylori, using simple blood, breath or stool tests. Writing in the journal Nature Medicine, they warn that if current trends continue unchecked, nearly 12 million people born between 2008 and 2017 will go on to develop stomach cancer due to the bacteria.“We found that about three-quarters of all stomach cancer cases globally could be prevented with proper screening and treatment,” said Dr Jin Young Park, lead author of the study and head of IARC’s gastric cancer prevention programme. “It is essential that health authorities make gastric cancer prevention a priority and accelerate efforts to control it.”Asia Is Most Affected, But The Risk Is GlobalWhile the highest number of predicted cases is expected in Asia, around 2 million are projected to develop in the Americas and 1.2 million in Europe.In the UK, data from Cancer Research UK (CRUK) shows that H. pylori is responsible for roughly 41 per cent of the 6,500 stomach cancer cases diagnosed annually—about 2,700 cases a year.Historically, about 40% of the British population has tested positive for H. pylori, although rates are now believed to be declining. However, the risk persists, especially among older generations or those born in areas where the bacteria is still widespread.Prevention Lies In Lifestyle ChangesDespite the global warning, CRUK has urged Britons not to panic. Dr Rachel Orritt, the charity’s health information manager, stressed that lifestyle factors such as smoking, poor diet, alcohol consumption and obesity remain more significant contributors to cancer risk in the UK, as reported by DailyMail.“Although this is an important issue worldwide, in the UK other preventable factors cause more cancer cases,” she said. “Ways to reduce your cancer risk include stopping smoking, keeping a healthy weight, cutting down on alcohol and eating a healthy, balanced diet.”CRUK also highlighted that over half of all stomach cancers in the UK are preventable, and that incidence rates have fallen by more than 25% in the past decade—a trend that is expected to continue.Early Signs You Should Not MissDoctors advise that persistent symptoms like indigestion, nausea, weight loss, or discomfort in the upper stomach lasting more than three weeks should prompt a visit to a GP. Around 18 people in the UK and 83 in the US are diagnosed with stomach cancer every day. The disease remains difficult to treat once advanced, with only 17 per cent of UK patients surviving beyond 10 years post-diagnosis.With screening and treatment, H. pylori infection can be managed—and lives saved. The challenge lies in catching it before it silently progresses to something far more dangerous.

Aarushi Bhadury

First UK Adult To Receive Treatment For Type 1 Diabetes Drug Undergoing Trials

-First UK Adult To Receive Treatment For Type 1 Diabetes Drug Undergoing Trials

Drinking Sugary Drinks Is Worse Than Eating Sugar - How You Consume It Matters More Than How Much

drinking sugary drinks is worse than eating sugar - how you consume it matters more than how much

You Are Three Times More Likely To Have Eye Diseases If You Are Dealing With This Health Condition

you are three times more likely to have eye diseases if you are dealing with this health condition

Why Does Your BBL Smell? Doctor Explains 4 Reasons That Could Cause It

why does your bbl smell? doctor explains 4 reasons that could cause  brazilian butt lift smell

Aspirin Isn’t Always Safe For Older Adults Anymore—Here's Why Doctors Are Warning Against It

aspirin isn’t always safe for older adults anymore—here's why doctors are warning against it

<span>Type 1 diabetes</span> is a condition that cannot be treated clinically and people with <span>diabetes</span> receive lifelong treatment to manage symptoms and keep their blood sugar under control. However, with the joint efforts of researchers all over the world and countless studies, trials for a new drug have begun in the UK. 

Right now, about 4.6 million people in the UK have diabetes, and over 270,000 of them have Type 1. Since there isn't a cure for Type 1 diabetes yet, most people need to take insulin every day to keep their blood sugar levels normal and avoid serious health problems. As you may know, insulin is a hormone responsible for turning food into energy by essentially breaking down the sugar to make it glucose. 

This new drug, Teplizumab, can change the way we deal with type 1 diabetes. Instead of taking long-term treatment measures, the success of this trial could mean potentially finding a cure in the future. This treatment is happening at the Royal Devon University Healthcare NHS Foundation Trust, and it's getting help from a group called the National Institute of Health and Care Research (NIHR). This is a big step forward because it might help people put off getting full-blown Type 1 diabetes.

Also Read: <a href="https://www.healthandme.com/health-wellness/study-suggests-six-personality-traits-that-make-us-cool-is-it-genetic-or-acquired-article-152242545" data-type="tilCustomLink" target="_blank">6 Personality Traits That Make Someone Cool – Are They Born With It or Can You Learn It? </a> 

<h2>Hannah Robinson: The First Adult Patient in the UK </h2>

Hannah Robinson, who is a dentist and a mom of two from Devon, is the first adult in the UK to try this new treatment. She found out during her pregnancy that she was starting to develop Type 1 diabetes. Familiar with the challenges of living with diabetes, Hannah hopes that taking this drug could mean she won't need to take daily insulin shots for up to three years longer than she would have otherwise. This would give her more freedom and control over her health. 

Hannah, who is 36, said: "I've learned a lot about Type 1 diabetes since I was diagnosed and what it means for my future. For me, this new drug gives me more freedom and a chance to focus on my health before I have to change my life and manage things as someone who needs daily insulin. It's not just about what I eat or checking my sugar; it's also about feeling more in control and not letting my condition define me. This treatment could even lead to a cure for Type 1 diabetes, which is amazing. I feel very lucky to be part of this." 

<h2>What is Type 1 Diabetes and How Teplizumab Helps </h2>

With Type 1 diabetes, your body's immune system attacks and destroys special cells in your pancreas called beta cells. These beta cells are very important because they make insulin, which helps control your blood sugar. If your blood sugar is too high or too low, it can cause serious health problems.

Also Read: <a href="https://www.healthandme.com/health-wellness/why-does-your-bbl-smell-doctor-explains-4-reasons-that-could-cause-brazilian-butt-lift-smell-article-152241539" data-type="tilCustomLink" target="_blank">Why Does Your BBL Smell? Doctor Explains 4 Reasons That Could Cause It</a>

The new drug, Teplizumab, works by teaching your immune system to stop attacking these beta cells. By doing this, it can delay you needing insulin by up to three years. But it's very important that the drug is given very early on, before the disease has gotten too far along. Teplizumab is already approved in the USA. Hannah is the first adult in the UK to get this treatment, though a small number of children and young people here have already received it in its early stages. 

Experts are saying that Teplizumab works best when it's given very early on, even before someone officially gets diagnosed with Type 1 diabetes based on high blood sugar. Dr. Nick Thomas, a top diabetes specialist at the University of Exeter, explained that this new treatment is a huge step forward. It allows doctors to step in early and change what the immune system is doing. The goal is to slow down how quickly people will need to start taking insulin. 

The research happening at the Royal Devon and the University of Exeter are using things like genetics and other tests to find people who are at a high risk of getting Type 1 diabetes. This smart approach means that more people could potentially get the drug early and delay the start of the disease. 

<h2>Insulin Free Future for Type-1 Diabetes Patients </h2>

Researchers involved in the study explain that trials like these can lead to many patients having some extra insulin free years. Their ultimate goal is a future where these types of immune-system treatments become the first line of defense against Type 1 diabetes, tackling the root cause of the problem. Hopefully, in the future, early treatment could even stop some people from ever needing insulin at all. 

Diabetes

Type 1 diabetes

Type 1 diabetes drug

type one diabetes drug trials

Can you cure type 1 diabetes

First UK Adult for Type 1 diabetes

Type 1 diabetes is a condition that cannot be treated clinically and people with diabetes receive lifelong treatment to manage symptoms and keep their blood sugar under control. However, with the joint efforts of researchers all over the world and countless studies, trials for a new drug have begun in the UK. Right now, about 4.6 million people in the UK have diabetes, and over 270,000 of them have Type 1. Since there isn't a cure for Type 1 diabetes yet, most people need to take insulin every day to keep their blood sugar levels normal and avoid serious health problems. As you may know, insulin is a hormone responsible for turning food into energy by essentially breaking down the sugar to make it glucose. This new drug, Teplizumab, can change the way we deal with type 1 diabetes. Instead of taking long-term treatment measures, the success of this trial could mean potentially finding a cure in the future. This treatment is happening at the Royal Devon University Healthcare NHS Foundation Trust, and it's getting help from a group called the National Institute of Health and Care Research (NIHR). This is a big step forward because it might help people put off getting full-blown Type 1 diabetes.Also Read: 6 Personality Traits That Make Someone Cool – Are They Born With It or Can You Learn It?  Hannah Robinson: The First Adult Patient in the UK Hannah Robinson, who is a dentist and a mom of two from Devon, is the first adult in the UK to try this new treatment. She found out during her pregnancy that she was starting to develop Type 1 diabetes. Familiar with the challenges of living with diabetes, Hannah hopes that taking this drug could mean she won't need to take daily insulin shots for up to three years longer than she would have otherwise. This would give her more freedom and control over her health. Hannah, who is 36, said: "I've learned a lot about Type 1 diabetes since I was diagnosed and what it means for my future. For me, this new drug gives me more freedom and a chance to focus on my health before I have to change my life and manage things as someone who needs daily insulin. It's not just about what I eat or checking my sugar; it's also about feeling more in control and not letting my condition define me. This treatment could even lead to a cure for Type 1 diabetes, which is amazing. I feel very lucky to be part of this." What is Type 1 Diabetes and How Teplizumab Helps With Type 1 diabetes, your body's immune system attacks and destroys special cells in your pancreas called beta cells. These beta cells are very important because they make insulin, which helps control your blood sugar. If your blood sugar is too high or too low, it can cause serious health problems.Also Read: Why Does Your BBL Smell? Doctor Explains 4 Reasons That Could Cause ItThe new drug, Teplizumab, works by teaching your immune system to stop attacking these beta cells. By doing this, it can delay you needing insulin by up to three years. But it's very important that the drug is given very early on, before the disease has gotten too far along. Teplizumab is already approved in the USA. Hannah is the first adult in the UK to get this treatment, though a small number of children and young people here have already received it in its early stages. Early Intervention is Key Experts are saying that Teplizumab works best when it's given very early on, even before someone officially gets diagnosed with Type 1 diabetes based on high blood sugar. Dr. Nick Thomas, a top diabetes specialist at the University of Exeter, explained that this new treatment is a huge step forward. It allows doctors to step in early and change what the immune system is doing. The goal is to slow down how quickly people will need to start taking insulin. The research happening at the Royal Devon and the University of Exeter are using things like genetics and other tests to find people who are at a high risk of getting Type 1 diabetes. This smart approach means that more people could potentially get the drug early and delay the start of the disease. Insulin Free Future for Type-1 Diabetes Patients Researchers involved in the study explain that trials like these can lead to many patients having some extra insulin free years. Their ultimate goal is a future where these types of immune-system treatments become the first line of defense against Type 1 diabetes, tackling the root cause of the problem. Hopefully, in the future, early treatment could even stop some people from ever needing insulin at all. 

first uk adult to receive treatment for type 1 diabetes drug undergoing trials

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

Man Walks Into ER Feeling Unwell, Hours Later Starts Hallucinating—Now He’s Battling A Rare Disorder That Mimics Mental Illness

Quick Stories

Overweight Women With Heart Disease Face 31% Higher Breast Cancer Risk

76% Of Stomach Cancer Cases Are Linked to This Common Infection, But Not Many Know About It

First UK Adult To Receive Treatment For Type 1 Diabetes Drug Undergoing Trials

Health Conditions A-Z

3 Medical Emergencies Schools Should Be Prepared For - Biggest Concerns For Paramedic Responses

A Mix Of 96 Chemicals And Hidden Toxins Found In 90% of U.S. Toddlers, Reveals NHS Study

Man Walks Into ER Feeling Unwell, Hours Later Starts Hallucinating—Now He’s Battling A Rare Disorder That Mimics Mental Illness